These pro-inflammatory cytokines, such as IL-6 and TNF-α, are released by both tumor and host immune cells and initiate a cascade of intracellular signaling pathways that culminate in skeletal muscle degradation and other systemic dysregulation [1]. This evidence concerns the gene IL6 and neoplasm.